Mohammed Alazazi, PharmD Candidate

Articles by Mohammed Alazazi, PharmD Candidate

Exploring the Antidepressant Potential of GLP-1 Receptor Agonists

ByMohammed Alazazi, PharmD Candidate,Ashar Akhtar, PharmD Candidate,Rohit Kumar, PharmD Candidate,Asya Sakar, PharmD Candidate,Chinonye Madunezim, PharmD,Joseph P. Nathan, PharmD, MS

September 10th 2025

GLP-1 receptor agonists show promise in alleviating depressive symptoms in patients with type 2 diabetes, offering a potential dual benefit in treatment.

Latest Updated Articles

Exploring the Antidepressant Potential of GLP-1 Receptor Agonists
Published: September 10th 2025 | Updated:

Mohammed Alazazi, PharmD Candidate

Articles by Mohammed Alazazi, PharmD Candidate

Exploring the Antidepressant Potential of GLP-1 Receptor Agonists

Latest Updated Articles

Trending on Pharmacy Times

A Multifaceted Approach to Navigating Career Transitions in Pharmacy

Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health

Menopause Care Varies by Provider, Highlighting Need for Standardized Education